Inhibiting autophagy increases epirubicin's cytotoxicity in breast cancer cells.
about
ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis.Autophagy in Cancer Therapy.Identification of Novel Bisbenzimidazole Derivatives as Anticancer Vacuolar (H⁺)-ATPase Inhibitors.Cold PSM, but not TRAIL, triggers autophagic cell death: A therapeutic advantage of PSM over TRAIL.Ambra1 modulates the sensitivity of breast cancer cells to epirubicin by regulating autophagy via ATG12
P2860
Inhibiting autophagy increases epirubicin's cytotoxicity in breast cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibiting autophagy increases epirubicin's cytotoxicity in breast cancer cells.
@en
Inhibiting autophagy increases epirubicin's cytotoxicity in breast cancer cells.
@nl
type
label
Inhibiting autophagy increases epirubicin's cytotoxicity in breast cancer cells.
@en
Inhibiting autophagy increases epirubicin's cytotoxicity in breast cancer cells.
@nl
prefLabel
Inhibiting autophagy increases epirubicin's cytotoxicity in breast cancer cells.
@en
Inhibiting autophagy increases epirubicin's cytotoxicity in breast cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
Inhibiting autophagy increases epirubicin's cytotoxicity in breast cancer cells.
@en
P2093
P2860
P304
P356
10.1111/CAS.13059
P577
2016-08-25T00:00:00Z